MedTrace Logo

Prospective Study With AMI Patients Undergoing PCI

NCT03038360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 620

Last updated 2023-05-23

No results posted yet for this study

Summary

CardioSAVE is a prospective 12-month controlled longitudinal study for the validation of a novel predictive model and a diagnostic tool, for the risk stratification of AMI patients undergoing PCI, with a one year follow-up.

Conditions

Sponsors & Collaborators

  • Herz-Zentrums Bad Krozingen

    collaborator OTHER

  • Firalis SA

    lead INDUSTRY

Principal Investigators

  • Hueseyin Firat, MD, PhD · Firalis SA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-10
Primary Completion
2020-11-30
Completion
2021-10-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038360 on ClinicalTrials.gov